1. Home
  2. MIST vs NAAS Comparison

MIST vs NAAS Comparison

Compare MIST & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • NAAS
  • Stock Information
  • Founded
  • MIST 2003
  • NAAS 2019
  • Country
  • MIST Canada
  • NAAS China
  • Employees
  • MIST N/A
  • NAAS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • NAAS Other Specialty Stores
  • Sector
  • MIST Health Care
  • NAAS Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • MIST 81.5M
  • NAAS 54.6M
  • IPO Year
  • MIST N/A
  • NAAS 2017
  • Fundamental
  • Price
  • MIST $1.43
  • NAAS $3.05
  • Analyst Decision
  • MIST Strong Buy
  • NAAS
  • Analyst Count
  • MIST 3
  • NAAS 0
  • Target Price
  • MIST $13.00
  • NAAS N/A
  • AVG Volume (30 Days)
  • MIST 177.8K
  • NAAS 179.6K
  • Earning Date
  • MIST 11-11-2024
  • NAAS 11-05-2024
  • Dividend Yield
  • MIST N/A
  • NAAS N/A
  • EPS Growth
  • MIST N/A
  • NAAS N/A
  • EPS
  • MIST N/A
  • NAAS N/A
  • Revenue
  • MIST N/A
  • NAAS $58,241,066.00
  • Revenue This Year
  • MIST N/A
  • NAAS $19.53
  • Revenue Next Year
  • MIST N/A
  • NAAS $151.36
  • P/E Ratio
  • MIST N/A
  • NAAS N/A
  • Revenue Growth
  • MIST N/A
  • NAAS 199.95
  • 52 Week Low
  • MIST $1.12
  • NAAS $1.42
  • 52 Week High
  • MIST $3.52
  • NAAS $61.60
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • NAAS 42.32
  • Support Level
  • MIST $1.41
  • NAAS $3.00
  • Resistance Level
  • MIST $1.53
  • NAAS $3.35
  • Average True Range (ATR)
  • MIST 0.07
  • NAAS 0.24
  • MACD
  • MIST -0.01
  • NAAS -0.03
  • Stochastic Oscillator
  • MIST 26.96
  • NAAS 20.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.

Share on Social Networks: